Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease

Abstract

Serum lipocalin-2 levels were significantly elevated in patients with CHD and were independently associated with CHD. The present findings suggest that the measurement of serum lipocalin-2 levels may be useful for assessing CHD risk.